Business Combination, Number Of Derivative Contracts

No definition available.

Name:	prgo_BusinessCombinationNumberOfDerivativeContracts
Namespace Prefix:	prgo_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Income from Sales Owned by Company, Percent

+ References

No definition available.

+ Details

Name:	prgo_IncomefromSalesOwnedbyCompanyPercent
Namespace Prefix:	prgo_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of Brands Acquired

+ References

No definition available.

+ Details

Name:	prgo_NumberOfBrandsAcquired
Namespace Prefix:	prgo_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275

+ Details

Name:	us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_BusinessAcquisitionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479

+ Details

Name:	us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 30
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 30
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477

+ Details

Name:	us-gaap_BusinessCombinationConsiderationTransferred1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

No definition available.

+ Details

Name:	us-gaap_FiniteLivedIntangibleAssetUsefulLife
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275

+ Details

Name:	us-gaap_FinitelivedIntangibleAssetsAcquired1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(10)(1))
-URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 55
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266

+ Details

Name:	us-gaap_Goodwill
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)(1)
-URI http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585

+ Details

Name:	us-gaap_PaymentsToAcquireBusinessesGross
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585

+ Details

Name:	us-gaap_PaymentsToAcquireIntangibleAssets
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareAmericasMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=prgo_ConsumerSelfCareInternationalMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=prgo_HRAPharmaMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_StatementScenarioAxis=srt_ScenarioForecastMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=prgo_SanofiBrandsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=prgo_BrandMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=prgo_OralCareAssetsofHighRidgeBrandsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=prgo_DexsilMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=prgo_SteripodMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=prgo_BrandedOTCRightsofPrevacidMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=prgo_GenericProductAcquisitionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=prgo_BudesonideNasalSprayandTriamcinoloneNasalSprayMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=prgo_RanirGlobalHoldingsLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=prgo_TrademarksTradeNamesandBrandsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Acquisitions and Divestitures - Narrative (Details) € in Millions, $ in Millions										1 Months Ended	6 Months Ended		9 Months Ended	12 Months Ended
	Oct. 30, 2020 EUR (€) brand	Oct. 30, 2020 USD ($) brand	Apr. 01, 2020 USD ($)	Feb. 13, 2020 USD ($)	Jan. 03, 2020 USD ($)	Nov. 29, 2019 USD ($)	Jul. 01, 2019 USD ($)	May 17, 2019 USD ($)	Apr. 01, 2019 USD ($)	Sep. 30, 2021 contract	Jul. 02, 2022 EUR (€)	Jul. 02, 2022 USD ($)	Dec. 31, 2020 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2019 USD ($)
Business Acquisition [Line Items]
Goodwill													$ 3,095.7	$ 2,999.4	$ 3,102.8
CSCA
Business Acquisition [Line Items]
Goodwill													1,905.0	1,902.4	1,899.1
CSCI
Business Acquisition [Line Items]
Goodwill													1,190.7	$ 1,097.0	$ 1,203.7
Developed product technology, formulations, and product rights
Business Acquisition [Line Items]
Useful life of intangible assets														8 years
HRA Pharma
Business Acquisition [Line Items]
Number of derivative contracts \| contract										2
HRA Pharma \| Forecast
Business Acquisition [Line Items]
Binding offer for acquisition											€ 1,800.0	$ 2,100.0
Sanofi Brands
Business Acquisition [Line Items]
Number of brands acquired \| brand	3	3
Purchase price paid	€ 53.3	$ 62.3
Useful life of intangible assets	18 years 9 months 18 days	18 years 9 months 18 days
Sanofi Brands \| Brand
Business Acquisition [Line Items]
Intangible assets acquired		$ 52.5
Oral Care Assets of High Ridge Brands (Dr. Fresh)
Business Acquisition [Line Items]
Binding offer for acquisition			$ 113.0
Purchase price paid													$ 106.2
Goodwill			$ 17.2
Weighted-average useful life (in years)			17 years 9 months 18 days
Dexsil \| Brand
Business Acquisition [Line Items]
Intangible assets acquired				$ 8.0
Weighted-average useful life (in years)				25 years
Steripod
Business Acquisition [Line Items]
Purchase price paid					$ 26.0
Steripod \| Brand
Business Acquisition [Line Items]
Intangible assets acquired					$ 25.1
Weighted-average useful life (in years)					25 years
Branded OTC Rights of Prevacid \| Brand \| CSCA
Business Acquisition [Line Items]
Intangible assets acquired						$ 61.7
Weighted-average useful life (in years)						20 years
Purchase price						$ 61.5
Generic Product Acquisition \| Developed product technology, formulations, and product rights
Business Acquisition [Line Items]
Weighted-average useful life (in years)								20 years
Purchase price								$ 15.7
Budesonide Nasal Spray and Triamcinolone Nasal Spray \| Developed product technology, formulations, and product rights
Business Acquisition [Line Items]
Weighted-average useful life (in years)									10 years
Purchase price									$ 14.0
Income from sales owned by Company (percent)									100.00%
Ranir Global Holdings, LLC
Business Acquisition [Line Items]
Purchase price paid							$ 759.2
Goodwill							292.7
Tax deductible goodwill							$ 252.3
Ranir Global Holdings, LLC \| CSCA
Business Acquisition [Line Items]
Goodwill														$ 212.6
Ranir Global Holdings, LLC \| CSCI
Business Acquisition [Line Items]
Goodwill														$ 80.1
Ranir Global Holdings, LLC \| Trademarks and trade names \| Minimum
Business Acquisition [Line Items]
Weighted-average useful life (in years)							20 years
Ranir Global Holdings, LLC \| Trademarks and trade names \| Maximum
Business Acquisition [Line Items]
Weighted-average useful life (in years)							25 years
Ranir Global Holdings, LLC \| Customer relationships and distribution networks
Business Acquisition [Line Items]
Weighted-average useful life (in years)							24 years
Ranir Global Holdings, LLC \| Developed product technology, formulations, and product rights
Business Acquisition [Line Items]
Weighted-average useful life (in years)							10 years